Posts

Terremoto Raises $108M to Make an 'Earthquake' in Small Molecule Space

Terremoto raised $108M in Series C funding 1 2 The funding will support clinical trial development of drugs targeting AKT 2 The company is focusing on small molecule drug development 1 The funding round has been reported as recent news across multiple biotech publications 1 2 Sources: 1. https://www.nie-podam.pl/wiadomosci/112258103 2. https://www.brutalist.bio

NeuraClick Expands Scientific and Translational Leadership with Key Advisory Appointments

Pivotal Pancreatic Cancer Data Fuels Revolution Medicines' Upsized $2B Offering

Beeline Biotech Launches with $300M Funding and Bristol Myers Squibb-Derived Pipeline

Magnetic Seizure Therapy Shows Efficacy and Safety Comparable to Electroconvulsive Therapy for Depression

Mike Sciandra's Journey from Gambling Addiction to Recovery and Advocacy

2026 AAPS National Biotechnology Conference: Plenary Speakers and Key Details Announced

Revolution Medicines Secures $2B Funding from Royalty Pharma for RAS Cancer Drugs as Biotech Sector Heats Up

Bristol Myers Squibb and Bain Capital Launch New Autoimmune Disease Biotech Company

Biogen's $5.6B Apellis Acquisition: Key Biotech Deals Including Telix's $600M Raise and Obsidian's IPO Plans

Spotlight On: Tackling Core Challenges in Drug R&D with AI

Johnson & Johnson Reports Strong Q1 Results and Raises 2026 Guidance

FDA Requests Additional Safety Data from Eli Lilly on Foundayo for Liver and Heart Risks